NO20054762D0 - Polymorphs of aripiprazole - Google Patents
Polymorphs of aripiprazoleInfo
- Publication number
- NO20054762D0 NO20054762D0 NO20054762A NO20054762A NO20054762D0 NO 20054762 D0 NO20054762 D0 NO 20054762D0 NO 20054762 A NO20054762 A NO 20054762A NO 20054762 A NO20054762 A NO 20054762A NO 20054762 D0 NO20054762 D0 NO 20054762D0
- Authority
- NO
- Norway
- Prior art keywords
- aripiprazole
- polymorphs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN412MU2003 | 2003-04-25 | ||
IN583MU2003 | 2003-06-06 | ||
PCT/IN2004/000113 WO2004106322A2 (en) | 2003-04-25 | 2004-04-22 | Polymorphs of aripiprazole |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054762D0 true NO20054762D0 (no) | 2005-10-17 |
NO20054762L NO20054762L (no) | 2006-01-24 |
Family
ID=33492303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054762A NO20054762L (no) | 2003-04-25 | 2005-10-17 | Polymorphs of aripiprazole |
Country Status (4)
Country | Link |
---|---|
US (1) | US20060270683A1 (no) |
EP (1) | EP1618103A2 (no) |
NO (1) | NO20054762L (no) |
WO (1) | WO2004106322A2 (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7714129B2 (en) | 2003-12-16 | 2010-05-11 | Teva Pharmaceutical Industries Ltd. | Methods of preparing anhydrous aripiprazole form II |
PL1613598T3 (pl) | 2003-12-16 | 2012-03-30 | Teva Pharma | Sposób wytwarzania krystalicznych form aripiprazolu |
MXPA06008829A (es) | 2004-02-05 | 2007-04-25 | Teva Pharma | Metodo de fabricar 7-(4-bromobutoxi)-3,4-dihidrocarboestirilo. |
US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
CN101111481A (zh) * | 2004-11-18 | 2008-01-23 | 斯索恩有限公司 | 制备结晶阿立哌唑的方法 |
US7884205B2 (en) * | 2005-01-27 | 2011-02-08 | Sandoz Ag | Salts of aripiprazole |
EP1686126A1 (en) * | 2005-01-27 | 2006-08-02 | Sandoz AG | Salts of aripiprazole |
CA2600542A1 (en) * | 2005-03-17 | 2006-09-21 | Synthon B.V. | Pharmaceutical tablets of crystalline type ii aripiprazole |
WO2006097343A1 (en) * | 2005-03-17 | 2006-09-21 | Synthon B.V. | Process of making crystalline type ii aripiprazole |
CA2605128A1 (en) * | 2005-04-15 | 2007-01-11 | Medichem, S.A. | Syntheses and preparations of polymorphs of crystalline aripiprazole |
HUP0500683A3 (en) * | 2005-07-14 | 2009-03-30 | Egis Gyogyszergyar Nyilvanosan | New arylpiprazole salts for producing pharmaceutical composition |
TW200800202A (en) * | 2005-12-22 | 2008-01-01 | Teva Pharma | Processes for reducing particle size of aripiprazole |
DK1808164T3 (da) * | 2006-01-05 | 2009-04-20 | Teva Pharma | Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol |
DK1808165T3 (da) * | 2006-01-05 | 2009-08-03 | Teva Pharma | Törre formuleringer af aripiprazol |
US7799790B2 (en) | 2006-07-20 | 2010-09-21 | Helm Ag | Amorphous aripiprazole and process for the preparation thereof |
EP1880714A1 (en) | 2006-07-20 | 2008-01-23 | Helm AG | Amorphous Aripiprazole and Process for the Preparation thereof |
WO2008020453A2 (en) * | 2006-08-17 | 2008-02-21 | Unichem Laboratories Limited | A process for the preparation of a novel crystalline polymorph of aripiprazole |
PL2082735T3 (pl) | 2008-01-23 | 2011-05-31 | Helm Ag | Amorficzny arypiprazol i sposób jego wytwarzania |
EP2238976B1 (en) | 2009-04-03 | 2012-06-27 | Hexal AG | Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof |
US9156822B2 (en) | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
AR033485A1 (es) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
-
2004
- 2004-04-22 US US10/554,366 patent/US20060270683A1/en not_active Abandoned
- 2004-04-22 WO PCT/IN2004/000113 patent/WO2004106322A2/en active Application Filing
- 2004-04-22 EP EP04770647A patent/EP1618103A2/en not_active Withdrawn
-
2005
- 2005-10-17 NO NO20054762A patent/NO20054762L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060270683A1 (en) | 2006-11-30 |
NO20054762L (no) | 2006-01-24 |
WO2004106322A2 (en) | 2004-12-09 |
WO2004106322A3 (en) | 2005-04-21 |
EP1618103A2 (en) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054762D0 (no) | Polymorphs of aripiprazole | |
CY2022001I2 (el) | Παραγωγα του uk-2a | |
LU92427I2 (fr) | Aripiprazole | |
IS8439A (is) | Nýjar kínólín afleiður | |
CY2017048I2 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
IS8108A (is) | Ný efnasambönd | |
SE0301569D0 (sv) | Novel compounds | |
DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
IS8228A (is) | Ný asetídínefnasambönd | |
IS8089A (is) | Efnasambönd | |
IS8399A (is) | Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns | |
IS8292A (is) | Ný efnasambönd | |
DE602004006228D1 (de) | Identifikation alternierender t-wellen | |
DK1516540T3 (da) | Anvendelse af vitamin D-forbindelser | |
DE502004005544D1 (de) | Mikrodosiereinrichtung | |
ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
ATE499348T1 (de) | Stabiler polymorph von bifeprunoxmesilat | |
FR2877833B1 (fr) | Correcteur de lordoses | |
NO20031736D0 (no) | Forbindelser | |
SE0303452D0 (sv) | New compounds | |
PT103053A (pt) | Micro-linha de extrusao | |
DE502004012380D1 (de) | Bekleidungsstück | |
ES1054157Y (es) | Higrotapon para puntero de gaita | |
DOP2004000824A (es) | Nuevos derivados de 2-piridinacarboxamida | |
ITMO20040025A1 (it) | Mezzi di collegamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |